nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in liquid biopsy for bone and soft-tissue sarcomas
|
Wang, Yilang |
|
|
30 |
9 |
p. 1722-1733 |
artikel |
2 |
A perspective on patient-derived orthotopic xenograft (PDOX) mouse models for identification of novel and individualized treatment for sarcoma
|
Higuchi, Takashi |
|
|
30 |
9 |
p. 1707-1721 |
artikel |
3 |
Association between increased proteinuria induced by Bevacizumab, Ramucirumab, and Aflibercept and the risk of renal impairment and failure: a systematic review and meta-analysis
|
Shibutani, Yuma |
|
|
30 |
9 |
p. 1743-1756 |
artikel |
4 |
Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study
|
Okamoto, Keisuke |
|
|
30 |
9 |
p. 1757-1763 |
artikel |
5 |
Characteristics of gut microbiota in high-methylated colorectal cancer
|
Saito, Tatsushi |
|
|
30 |
9 |
p. 1805-1817 |
artikel |
6 |
Clinical utility of a novel perioperative quality assessment metric, trifecta, for radical cystectomy
|
Atsuta, Mahito |
|
|
30 |
9 |
p. 1832-1840 |
artikel |
7 |
Correction to: Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study
|
Fujisawa, Yasuhiro |
|
|
30 |
9 |
p. 1882-1883 |
artikel |
8 |
Current and emerging systemic treatment options for malignant fibrous histiocytoma/undifferentiated pleomorphic sarcoma
|
Miwa, Shinji |
|
|
30 |
9 |
p. 1734-1742 |
artikel |
9 |
Different outcomes by sex in metastatic gastrointestinal stromal tumor patients receiving imatinib: a trial-level analysis
|
Venturino, Antonella |
|
|
30 |
9 |
p. 1797-1804 |
artikel |
10 |
Factors associated with primary resistance to enfortumab vedotin in previously treated patients with metastatic urothelial carcinoma: a multicenter retrospective study
|
Ikarashi, Daiki |
|
|
30 |
9 |
p. 1841-1848 |
artikel |
11 |
Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer
|
Suzuki, Satoshi |
|
|
30 |
9 |
p. 1764-1774 |
artikel |
12 |
Onco-nephrology in clinical practice: pharmacokinetics, monitoring, and treatment strategies for patients with cancer and impaired renal function
|
Nakagawa, Shunsaku |
|
|
30 |
9 |
p. 1700-1706 |
artikel |
13 |
Outcomes of cases with complete hydatidiform mole coexisting with a fetus: a single-center study
|
Niimi, Kaoru |
|
|
30 |
9 |
p. 1866-1872 |
artikel |
14 |
Phase II study of afatinib for advanced non-small cell lung cancer with uncommon epidermal growth factor receptor mutations, including compound mutations detected by next-generation sequencing
|
Mamesaya, Nobuaki |
|
|
30 |
9 |
p. 1787-1796 |
artikel |
15 |
Platinum-rechallenge in epithelial ovarian cancer relapsing within 6 months after first-line treatment: a propensity score matching analysis
|
Vertechy, Laura |
|
|
30 |
9 |
p. 1873-1881 |
artikel |
16 |
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; nivolumab plus ipilimumab for hepatocellular carcinoma, fedratinib for myelofibrosis, talquetamab for multiple myeloma, and belzutifan for tumors associated with von Hippel-Lindau disease and renal cell carcinoma
|
Matsumura, Noriomi |
|
|
30 |
9 |
p. 1679-1680 |
artikel |
17 |
Pterygomandibular raphe invasion as a novel grading and prognostic factor for squamous cell carcinoma of buccal mucosa: a retrospective study with propensity score matching
|
Yoshida, Ryoji |
|
|
30 |
9 |
p. 1775-1786 |
artikel |
18 |
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study
|
Yoneyama, Fumiya |
|
|
30 |
9 |
p. 1858-1865 |
artikel |
19 |
Risk stratification for recurrence after nephrectomy in high-risk renal cell carcinoma patients
|
Tobe, Taisuke |
|
|
30 |
9 |
p. 1849-1857 |
artikel |
20 |
The Metazoan SpoT Homolog 1 promotes ferroptosis by regulating the intracellular redox cycle and iron levels in hepatocellular carcinoma
|
Nakayama, Yuki |
|
|
30 |
9 |
p. 1818-1831 |
artikel |
21 |
The nationwide survey of Japanese public opinion about off-label use of anticancer drugs recommended by comprehensive genomic profiling
|
Matsubara, Junichi |
|
|
30 |
9 |
p. 1692-1699 |
artikel |
22 |
Treatment strategies and prognosis of superficial laryngo-pharyngeal cancer: a literature review
|
Ohno, Kazuchika |
|
|
30 |
9 |
p. 1681-1691 |
artikel |